Le Lézard
Classified in: Health, Science and technology
Subject: SLS

BioCatch Surpasses $100m USD ARR


BioCatch Becomes Centaur with more than 50% Growth YoY in Annual Recurring Revenue (ARR); Achieves Profitability While Scaling Operations & Global Reach Faster than any Other Behavioral-Powered Digital Fraud Prevention Vendor in History

TEL AVIV, Israel and NEW YORK, Nov. 20, 2023 /PRNewswire/ -- BioCatch, the global leader in digital fraud and money laundering detection and response powered by behavioral biometric intelligence, today announced that it has reached Centaur status, surpassing $100m in annual recurring revenue.

BioCatch is the leader in Behavioral Biometrics, a technology that leverages machine learning to analyze an online user's physical and cognitive digital behavior to protect individuals online.

The milestone achievement is fueled by the rapid adoption of BioCatch Connecttm, the Company's flagship product portfolio. In particular, BioCatch saw accelerated growth among its recently released scam and mule detection modules as customers look to protect their users against sophisticated social engineering scams and eliminate criminal money laundering networks from their ecosystems. Overall, BioCatch grew ARR 51% as of September 30, 2023 compared to September 30, 2022.

In 2023, BioCatch has achieved additional significant operational milestones including:

A significant reason for BioCatch's ARR growth and market expansion is the value and return on investment the BioCatch ConnectÔ portfolio of products delivers to its customers. These returns include an average of 1,500% improvement in fraudulent account detection, an 80% reduction in transaction-related fraud rates, a 40% improvement in customer experience, a 30% reduction in false positive rates and a 30% improvement in fraud team efficiency and throughput in comparison to first-generation digital fraud detection platforms. Behavioral Biometric Intelligence is a unique tool for detecting and preventing emerging scams and financial crimes and has the added benefit of improving customer experience by simplifying and streamlining a user's online banking transaction.

"BioCatch has experienced incredible growth in the last few years, especially in these last 12 months, thanks to best-in-market customer service, flawless go-to-market execution, and innovative market product development.  Fraud and financial crime are accelerating faster than banks can manage, not because they are not innovating, but because criminals are targeting customers, not systems," said Rajeev Dham, Partner at Sapphire Ventures. "We believe the future of financial crime prevention is behavior and we are excited to partner with a company that is the clear leader in this new frontier of digital fraud fighting."

"Achieving centaur status is a direct reflection of the value we provide to our customers and how we enable them to protect their users online," said Gadi Mazor, CEO of BioCatch. "Behavior is the only true signal of a customer's identity and motivations.  As scams, mobile malware, bots and remote access tools surge, user protection ? rather than system security ? is key.  Our outstanding technology, dedicated employees and collaborative partnership with customers has led to our success and will continue to fuel our growth and market leadership in the years ahead."

About BioCatch 

BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust and ease coexist. Today, more than 28 of the world's leading 100 banks and 152 of the largest 500 rely on BioCatch ConnectÔ to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch's Client Innovation Board, an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank, collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 90 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, please visit www.biocatch.com.

Media Contact:
Jay Jones
[email protected] 
404.668.0218

Logo - https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg


These press releases may also interest you

at 12:05
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 12:00
AlphaLab Health, an accelerator program developed by Innovation Works and Allegheny Health Network for life-sciences startups in the Pittsburgh region, has received a $10 million grant from an anonymous donor to create an evergreen fund. The...

at 12:00
Badge Inc., the award-winning privacy company enabling Identity without Secretstm, today announced integration with Premise Health, the world's leading direct healthcare provider and one of the largest digital providers in the country, to tackle the...

at 11:43
Enzymatica AB (publ) held its annual general meeting on May 7, 2024. At the annual general meeting, the following resolutions were made. Income statements and balance sheets The general meeting resolved to adopt the income statement and the balance...

at 11:31
Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts: Unauthorized sexual enhancement productsHealth Canada...

at 11:30
May 7, 2024 Amsterdam, the Netherlands ? Royal Philips , today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re-appointment of Chairman...



News published on and distributed by: